Analyst Ratings for Emergent Biosolutions Inc. (EBS)

Updated: 2017-07-27

Analysts covering Emergent Biosolutions Inc. (NYSE:EBS) have given it a consensus rating of Buy. A consensus rating of Buy was previously issued for EBS last month.

A buy rating was issued by 5 analysts, 0 gave an overweight rating, 1 gave a hold rating, 0 gave an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. During this time, the number of analysts bearish on the stock has increased by 0.

A number of analysts gave price targets for EBS. The highest price target was 50, which equates to a potential upside of 38.7 percent. The most pessimistic analyst gave a price target of 33, which equates to a potential downside of -8.46 percent. Many analysts are not unbiased in their coverage of stocks, including price targets and stock ratings, so care must be taken in interpreting numbers released by them.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 0 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is -33.43 percent. On the other hand, earnings estimates for the fiscal year have been revised upwards by 0 percent, as compared to a month ago. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 4.29 percent.

People are often interested in whether analysts were united in the direction of their revisions. Over the past month, 0 analysts increased their quarterly estimates, which can be compared to the 0 analysts that decreased their estimates. Also over the last month, 0 analysts increased their estimates for the FY earnings, compared to 0 analysts that revised their FY estimates downwards.

The growth rate of EBS's earnings is estimated by analysts to be 27.19 percent. It's possible to gain additional insight about growth valuation of a company by looking at the PEG ratio. A lower PEG ratio is favorable, as that can indicate whether the high price level of a stock is warranted by high growth. People often look for the PEG ratio to be under 1, even though it may be more relevant to compare the ratio to that of a firm's competitors. The PEG ratio of EBS is 1.11.

In the last 52-weeks, EBS has achieved a high of 36.64 and a low of 24.47. The current market price is above the trailing year's low by 47.32 percent, and 1.61 percent below the high. EBS has a price/earnings ratio of 30.31. Investors typically compare the P/E ratio to a company's peers in the industry. The EBS value stock report compares EBS to some of its peers using value stock charts. The stock has a market capitalization of $1.48 billion. EBS's next earnings release will be on 0000-00-00, which is days away.